FOLD
Amicus Therapeutics Inc
Price:  
9.66 
USD
Volume:  
3,165,807.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

FOLD Relative Valuation

-246.1%
Upside

As of 2024-05-27, the Relative Valuation of Amicus Therapeutics Inc (FOLD) is (14.11) USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.66 USD, the upside of Amicus Therapeutics Inc based on Relative Valuation is -246.1%.

The range of the Relative Valuation is (13.95) - (14.15) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 28.1x - 29.3x 28.7x
Forward P/E multiples 27.8x - 28.5x 28.2x
Fair Price (13.95) - (14.15) (14.11)
Upside -244.4% - -246.5% -246.1%
9.66 USD
Stock Price
(14.11) USD
Fair Price

FOLD Relative Valuation - Historical P/E Data

Date P/E
2024-05-24 -19.46
2024-05-23 -19.07
2024-05-22 -19.58
2024-05-21 -19.96
2024-05-20 -19.64
2024-05-17 -19.27
2024-05-16 -19.13
2024-05-15 -19.46
2024-05-14 -18.79
2024-05-13 -18.21
2024-05-10 -18.59
2024-05-09 -19.09
2024-05-08 -20.42
2024-05-07 -20.99
2024-05-06 -20.82
2024-05-03 -20.95
2024-05-02 -21.01
2024-05-01 -21.01
2024-04-30 -20.12
2024-04-29 -20.64
2024-04-26 -20.70
2024-04-25 -20.48
2024-04-24 -21.23
2024-04-23 -21.57
2024-04-22 -21.79
2024-04-19 -21.37
2024-04-18 -20.80
2024-04-17 -21.25
2024-04-16 -21.27
2024-04-15 -21.47
2024-04-12 -21.51
2024-04-11 -22.60
2024-04-10 -22.70
2024-04-09 -23.66
2024-04-08 -23.36
2024-04-05 -23.60
2024-04-04 -23.08
2024-04-03 -22.90
2024-04-02 -22.90
2024-04-01 -23.66
2024-03-28 -23.72
2024-03-27 -23.89
2024-03-26 -23.02
2024-03-25 -23.24
2024-03-22 -23.22
2024-03-21 -23.54
2024-03-20 -24.17
2024-03-19 -23.85
2024-03-18 -23.32
2024-03-15 -23.12